Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

**NM signifies a non meaningful value. A dash signifies the data is not available.

Discover why Gilead Sciences is a strong buy with potential blockbuster drugs in HIV and oncology, favorable valuation, and a ...

On the other hand, Gilead Sciences' revenue is growing nicely, at a compound rate of 4.8% over the last five years. It's ...

Future Financial Wealth Managment LLC acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

InvestingPro Tips highlight Gilead's financial strength and market position. The company has raised its dividend for 9 consecutive years, offering a current dividend yield of 3.58%. This ...

InvestingPro Tips highlight Gilead's commitment to shareholder value. The company has raised its dividend for 9 consecutive years, currently offering a dividend yield of 3.64%. This consistent ...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.